Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Investigate Business Mastercard Choices for Better Rewards and Rewards - 25 Worldwide Road Food varieties You Should Attempt
- 3Find the Standards of Viable Refereeing: Settling Debates with Strategy
- 4Nine in 10 German industrial firms expect Iran war to hit business
- 5Is relief in sight? Flu season still brutal but cases are declining.
- Twins were the norm for our ancient primate ancestors − one baby at a time had evolutionary advantages
- The Golden Globes is happening Sunday: Who's nominated, who's hosting and how to watch
- Hilary Duff releases 'Mature,' her 1st song in 10 years
- Israeli forces kill one person in series of attacks on southern Lebanon
- Artemis moon mission breaks record for distance from Earth
- 2024's Hot Games: Must-Play Titles of the Year
- Investigating Cooking and Culinary Expressions: An Excursion Through Flavors
- 'Unreal' solar eclipse: Artemis 2 crew just saw one of the rarest sights in spaceflight history
- Artemis II crew take new photo of far side of the moon
